Dan R. Littman's most recent trade in Pfizer Inc. was a trade of 8,999 Phantom Stock Units done . Disclosure was reported to the exchange on April 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | Dan R. Littman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2025 | 8,999 | 62,509 | - | - | Phantom Stock Units | |
| Pfizer | Dan R. Littman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 8,115 | 50,295 | - | - | Phantom Stock Units | |
| Pfizer | Dan R. Littman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 5,291 | 40,059 | - | - | Phantom Stock Units | |
| Pfizer | Dan R. Littman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 4,058 | 33,591 | - | - | Phantom Stock Units | |
| Pfizer | Dan R. Littman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2021 | 4,981 | 28,546 | - | - | Phantom Stock Units |